Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar rats
Rationale Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction. Materials and methods We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chl...
Saved in:
Published in | Psychopharmacologia Vol. 211; no. 4; pp. 367 - 375 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer-Verlag
01.09.2010
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rationale
Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction.
Materials and methods
We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3
H
-thieno[3,2-
d
]pyrimidin-4-one; 3–30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats.
Results
Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected.
Conclusion
Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders. |
---|---|
AbstractList | RATIONALE: Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction.
MATERIALS AND METHODS: We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3H-thieno[3,2-d]pyrimidin-4-one; 3-30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats.
RESULTS: Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected.
CONCLUSION: Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders. Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction. We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3H-thieno[3,2-d]pyrimidin-4-one; 3-30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats. Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected. Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders.[PUBLICATION ABSTRACT] Rationale: Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction. Materials and methods: We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phe n yl]-3H-thieno[3,2-d]pyrimidin-4-on e; 3-30mg/kg, i.p.] on alcohol-related behaviors in Wistar rats. Results: Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected. Conclusion: Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders. Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction. We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3H-thieno[3,2-d]pyrimidin-4-one; 3-30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats. Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected. Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders. Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction.RATIONALEMelanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction.We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3H-thieno[3,2-d]pyrimidin-4-one; 3-30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats.MATERIALS AND METHODSWe evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3H-thieno[3,2-d]pyrimidin-4-one; 3-30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats.Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected.RESULTSEx vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected.Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders.CONCLUSIONTogether, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders. Rationale Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction. Materials and methods We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3 H -thieno[3,2- d ]pyrimidin-4-one; 3–30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats. Results Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected. Conclusion Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders. |
Author | Gehlert, Donald R. Cippitelli, Andrea Heilig, Markus Karlsson, Camilla Shaw, Janice L. Thorsell, Annika |
Author_xml | – sequence: 1 givenname: Andrea surname: Cippitelli fullname: Cippitelli, Andrea organization: Laboratory of Clinical and Translational Studies, National Institute of Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) – sequence: 2 givenname: Camilla surname: Karlsson fullname: Karlsson, Camilla organization: Laboratory of Clinical and Translational Studies, National Institute of Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) – sequence: 3 givenname: Janice L. surname: Shaw fullname: Shaw, Janice L. organization: Neuroscience and Endocrine Discovery Research, Lilly Research Laboratories, a Division of Eli Lilly and Company – sequence: 4 givenname: Annika surname: Thorsell fullname: Thorsell, Annika organization: Laboratory of Clinical and Translational Studies, National Institute of Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) – sequence: 5 givenname: Donald R. surname: Gehlert fullname: Gehlert, Donald R. organization: Neuroscience and Endocrine Discovery Research, Lilly Research Laboratories, a Division of Eli Lilly and Company – sequence: 6 givenname: Markus surname: Heilig fullname: Heilig, Markus email: markus.heilig@mail.nih.gov organization: Laboratory of Clinical and Translational Studies, National Institute of Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23066889$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20628734$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-101840$$DView record from Swedish Publication Index |
BookMark | eNqFkstuFDEQRVsoiEwCH8AGWUgIWBjKj34toyEQpCAknkvL47YnDt12Y3crmp_hW6lhhkREAryxrTq3qq5dR8VBiMEWxUMGLxhA_TIDcCYoMKCsaRnd3CkWTApOOdT8oFgACEEFK5vD4ijnS8AlG3mvOORQ8aYWclH8-DiPY7I5-xhIdET3Jl7EnmTbO6q7wQefp6SnbViHjiTrQ570ZAcbpj8F9psPa7LakMH2OvhATQwGqa0aAxcxDdg-ZjB2nGIijDx7tzxj9MNzzDzpdcRSA_GBfMWSOhHU5fvFXaf7bB_s9-Pi8-vTT8szev7-zdvlyTk1soaJSgeldLZtmXEddFXLV8JUlevK2lg0KzuzPeu2bDvmADS4tu4EMLdyTpZSHBd0lzdf2XFeqTH5QaeNitqrV_7LiYpprXo_KwaskYD80x0_pvh9tnlSg8_G9mjcxjmrupRl1bCy-j8pJEAjpEDy8S3yMs4poG1Vc46eOK8RerSH5tVgu-tGf_8oAk_2gM5G9y7pYHy-4QRUVdO0yLEdZ1LMOVl3jTBQ2-lSu-lSsL3jdKkNaupbGuOnX7OBn-z7fyr5_n2xSljbdOPt76KfJE7lYA |
CODEN | PSYPAG |
CitedBy_id | crossref_primary_10_3389_fpsyt_2021_712163 crossref_primary_10_1038_s41386_018_0054_4 crossref_primary_10_1371_journal_pone_0110385 crossref_primary_10_3390_molecules26051291 crossref_primary_10_1186_s13293_024_00608_0 crossref_primary_10_1016_j_pnpbp_2015_02_006 crossref_primary_10_1038_s41598_017_01043_5 crossref_primary_10_1016_j_physbeh_2011_04_054 crossref_primary_10_1007_s00213_016_4385_8 crossref_primary_10_1021_ci4000882 crossref_primary_10_3389_fnut_2016_00011 crossref_primary_10_1016_j_pnpbp_2022_110536 crossref_primary_10_1080_14737175_2022_2031983 crossref_primary_10_1038_mp_2016_131 crossref_primary_10_1111_bph_12735 crossref_primary_10_4199_C00159ED1V01Y201711ISP079 crossref_primary_10_1016_j_biopsych_2012_12_027 crossref_primary_10_1016_j_yhbeh_2015_11_005 crossref_primary_10_1007_s00213_016_4285_y crossref_primary_10_1111_j_1369_1600_2012_00455_x crossref_primary_10_1111_acer_13181 crossref_primary_10_1016_j_neuroscience_2015_09_020 crossref_primary_10_1186_s12974_020_01875_5 crossref_primary_10_3389_fnsys_2017_00032 crossref_primary_10_1017_S1461145713000072 crossref_primary_10_1007_s00213_020_05532_w crossref_primary_10_1016_j_pbb_2023_173649 crossref_primary_10_1016_j_neulet_2020_135347 crossref_primary_10_1038_s41380_018_0064_y crossref_primary_10_1016_j_brainres_2020_146872 crossref_primary_10_1016_j_pbb_2019_06_001 crossref_primary_10_3389_fnins_2022_952275 crossref_primary_10_1523_JNEUROSCI_0637_18_2018 crossref_primary_10_1016_j_neuropharm_2022_109046 crossref_primary_10_1111_adb_12125 crossref_primary_10_1523_JNEUROSCI_4571_14_2015 crossref_primary_10_1007_s00213_011_2201_z crossref_primary_10_1016_j_neuroscience_2019_10_013 crossref_primary_10_1111_j_1369_1600_2012_00468_x crossref_primary_10_1038_npp_2010_191 crossref_primary_10_1016_j_euroneuro_2016_08_014 crossref_primary_10_1016_j_neuropharm_2015_02_005 crossref_primary_10_1523_JNEUROSCI_0790_23_2024 |
Cites_doi | 10.1016/j.biopsych.2007.12.011 10.1016/S0024-3205(03)00408-9 10.1016/j.pbb.2004.02.012 10.1210/en.143.7.2469 10.1111/j.1460-9568.2005.04056.x 10.1002/cne.1191 10.1097/01.ALC.0000167741.42353.10 10.1016/j.pbb.2006.11.004 10.1007/s00213-002-1224-x 10.1038/sj.npp.1300881 10.1038/nrn1406 10.1073/pnas.052706899 10.1016/j.bmcl.2006.07.008 10.1002/cne.903190204 10.1111/j.1360-0443.2004.00763.x 10.1124/jpet.102.044826 10.1111/j.1530-0277.2007.00427.x 10.1046/j.1460-9568.2000.00008.x 10.1007/s00213-008-1104-0 10.1523/JNEUROSCI.4079-04.2005 10.1007/s00213-009-1523-6 10.1111/j.1369-1600.2007.00079.x 10.1124/pr.54.1.1 10.1523/JNEUROSCI.1714-04.2005 10.1007/s00213-004-2036-y 10.1006/geno.2002.6771 10.1124/jpet.108.143362 10.2165/00063030-200721050-00003 10.1007/s00213-003-1393-2 10.1016/j.pharmthera.2006.02.001 10.1073/pnas.0811331106 10.1021/bi0200514 10.1038/305321a0 10.1210/endo.143.7.8903 10.1111/j.1530-0277.1998.tb03876.x 10.1016/S0022-3565(25)39420-6 10.1111/j.1527-3458.2005.tb00052.x 10.1038/nm0902-1039b 10.1016/j.brainres.2005.09.005 |
ContentType | Journal Article |
Copyright | US Government 2010 2015 INIST-CNRS Springer-Verlag 2010 |
Copyright_xml | – notice: US Government 2010 – notice: 2015 INIST-CNRS – notice: Springer-Verlag 2010 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 ADTPV AOWAS DG8 |
DOI | 10.1007/s00213-010-1891-y |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic SwePub SwePub Articles SWEPUB Linköpings universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Psychology Chemoreception Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 375 |
ExternalDocumentID | oai_DiVA_org_liu_101840 2092550581 20628734 23066889 10_1007_s00213_010_1891_y |
Genre | Journal Article |
GroupedDBID | -4W -BR .55 3SX 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS KOW N2Q R9- RHV SBY SOJ X7M ~EX AAYXX CITATION IQODW --- -56 -5G -EM -Y2 -~C .86 .GJ .VR 04C 06C 06D 0R~ 0VY 123 199 1N0 1SB 2.D 203 28- 29P 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2QV 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTAH ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACNCT ACOKC ACOMO ACPIV ACPRK ACUHS ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. B0M BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DL5 DNIVK DPUIP DU5 DWQXO DXH EAD EAP EBC EBD EBLON EBS ECM EIF EIHBH EIOEI EJD EMB EMK EMOBN EN4 EPAXT EPL EPS ESBYG ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICJ IHE IHR IJ- IKXTQ IMOTQ INH INR IPY ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M2M M4Y MA- MK0 N9A NAPCQ NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF- PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TN5 TSG TSK TSV TUC TUS U2A U9L UAP UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WIP WJK WK6 WK8 WOW XOL YLTOR YQJ YYP Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZY4 ~8M 7QG 7QR 7TK 7XB 8FD 8FK FR3 K9. P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 AAPKM ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA ADTPV AOWAS DG8 |
ID | FETCH-LOGICAL-c470t-4f054fe991cfd0d692b3c66fd57ce2064dcfd57a959d1f00a0f97d301fbff4543 |
IEDL.DBID | 7X7 |
ISSN | 0033-3158 1432-2072 |
IngestDate | Thu Aug 21 07:06:49 EDT 2025 Thu Jul 10 16:49:27 EDT 2025 Fri Jul 11 03:43:57 EDT 2025 Sat Aug 16 22:21:54 EDT 2025 Wed Feb 19 02:30:56 EST 2025 Wed Apr 02 07:26:53 EDT 2025 Thu Apr 24 23:08:41 EDT 2025 Sun Jul 06 05:07:35 EDT 2025 Fri Feb 21 02:34:21 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Footshock Alcohol Saccharin MCH1-R Seeking Reinstatement Affect affectivity Rat Rodentia Emotion emotionality Self administration Experimental study Alcoholic beverage Vertebrata Mammalia Animal Melanin concentrating hormone |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c470t-4f054fe991cfd0d692b3c66fd57ce2064dcfd57a959d1f00a0f97d301fbff4543 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 20628734 |
PQID | 722692227 |
PQPubID | 47309 |
PageCount | 9 |
ParticipantIDs | swepub_primary_oai_DiVA_org_liu_101840 proquest_miscellaneous_754568156 proquest_miscellaneous_734008343 proquest_journals_722692227 pubmed_primary_20628734 pascalfrancis_primary_23066889 crossref_primary_10_1007_s00213_010_1891_y crossref_citationtrail_10_1007_s00213_010_1891_y springer_journals_10_1007_s00213_010_1891_y |
PublicationCentury | 2000 |
PublicationDate | 2010-09-01 |
PublicationDateYYYYMMDD | 2010-09-01 |
PublicationDate_xml | – month: 09 year: 2010 text: 2010-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Berlin – name: Germany – name: Heidelberg |
PublicationTitle | Psychopharmacologia |
PublicationTitleAbbrev | Psychopharmacology |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 2010 |
Publisher | Springer-Verlag Springer Springer Nature B.V |
Publisher_xml | – name: Springer-Verlag – name: Springer – name: Springer Nature B.V |
References | Chen, Hu, Hsu, Zhang, Bi, Asnicar, Hsiung, Fox, Slieker, Yang, Heiman, Shi (CR8) 2002; 143 Smith, Davis, Rorick-Kehn, Morin, Witkin, McKinzie, Nomikos, Gehlert (CR36) 2006; 31 Chaki, Hirota, Funakoshi, Suzuki, Suetake, Okubo, Ishii, Nakazato, Okuyama (CR6) 2003; 304 Kawauchi, Kawazoe, Tsubokawa, Kishida, Baker (CR24) 1983; 305 Chung, Hopf, Nagasaki, Li, Belluzzi, Bonci, Civelli (CR9) 2009; 106 Georgescu, Sears, Hommel, Barrot, Bolanos, Marsh, Bednarek, Bibb, Maratos-Flier, Nestler, DiLeone (CR17) 2005; 25 Smith, Tzavara, Shaw, Luecke, Wade, Davis, Salhoff, Nomikos, Gehlert (CR35) 2005; 25 Weiss, Lorang, Bloom, Koob (CR38) 1993; 267 Duncan, Sorrell, Adamantidis, Rider, Jandacek, Seeley, Lakaye, Woods (CR15) 2007; 31 Goodwin, Amit (CR19) 1998; 22 Hervieu, Cluderay, Harrison, Meakin, Maycox, Nasir, Leslie (CR22) 2000; 12 Marsh, Weingarth, Novi, Chen, Trumbauer, Chen, Guan, Jiang, Feng, Camacho, Shen, Frazier, Yu, Metzger, Kuca, Shearman, Gopal-Truter, MacNeil, Strack, MacIntyre, Van der Ploeg, Qian (CR27) 2002; 99 Borowsky, Durkin, Ogozalek, Marzabadi, DeLeon, Lagu, Heurich, Lichtblau, Shaposhnik, Daniewska, Blackburn, Branchek, Gerald, Vaysse, Forray (CR3) 2002; 8 Wise (CR39) 2004; 5 Chaki, Yamaguchi, Yamada, Thomsen, Tran, Semple, Sekiguchi (CR7) 2005; 11 Cippitelli, Cannella, Braconi, Duranti, Tontini, Bilbao, Defonseca, Piomelli, Ciccocioppo (CR11) 2008; 198 Shalev, Grimm, Shaham (CR34) 2002; 54 Shaham, Shalev, Lu, de Wit, Stewart (CR33) 2003; 168 Morens, Norregaard, Receveur, van Dijk, Scheurink (CR28) 2005; 1062 Pissios, Frank, Kennedy, Porter, Marino, Liu, Pothos, Maratos-Flier (CR30) 2008; 64 Bouza, Angeles, Munoz, Amate (CR4) 2004; 99 Bednarek, Hreniuk, Tan, Palyha, MacNeil, Van der Ploeg, Howard, Feighner (CR1) 2002; 41 Kalivas, McFarland (CR23) 2003; 168 Saito, Cheng, Leslie, Civelli (CR32) 2001; 435 Heilig, Egli (CR20) 2006; 111 Gehlert, Rasmussen, Shaw, Li, Ardayfio, Craft, Coskun, Zhang, Chen, Witkin (CR16) 2009; 329 Hertzog, Al-Barazanji, Bigharn, Bishop, Britt, Carlton, Cooper, Daniels, Garrido, Goetz, Grizzle, Guo, Handlon, Ignar, Morgan, Peat, Tavares, Zhou (CR21) 2006; 16 Kowalski, Sasikumar (CR25) 2007; 21 Tan, Sano, Iwaasa, Pan, Sailer, Hreniuk, Feighner, Palyha, Pong, Figueroa, Austin, Jiang, Yu, Ito, Ito, Ito, Guan, MacNeil, Kanatani, Van der Ploeg, Howard (CR37) 2002; 79 Catania (CR5) 1992 DiLeone, Georgescu, Nestler (CR12) 2003; 73 Le, Harding, Juzytsch, Funk, Shaham (CR26) 2005; 179 Duncan, Proulx, Woods (CR13) 2005; 29 Cippitelli, Bilbao, Hansson, Del Arco, Sommer, Heilig, Massi, Bermudez-Silva, Navarro, Ciccocioppo, De Fonseca (CR10) 2005; 21 Bittencourt, Presse, Arias, Peto, Vaughan, Nahon, Vale, Sawchenko (CR2) 1992; 319 Gilpin, Stewart, Elder, Kho, Murphy, Li, Badia-Elder (CR18) 2004; 78 Duncan, Rider, Jandacek, Clegg, Benoit, Tso, Woods (CR14) 2006; 85 Rimondini, Sommer, Dall’olio, Heilig (CR31) 2008; 13 Nair, Adams-Deutsch, Pickens, Smith, Shaham (CR29) 2009; 205 Y Shaham (1891_CR33) 2003; 168 EA Duncan (1891_CR14) 2006; 85 P Pissios (1891_CR30) 2008; 64 EA Duncan (1891_CR13) 2005; 29 JC Bittencourt (1891_CR2) 1992; 319 R Rimondini (1891_CR31) 2008; 13 DL Hertzog (1891_CR21) 2006; 16 AD Le (1891_CR26) 2005; 179 C Bouza (1891_CR4) 2004; 99 S Chung (1891_CR9) 2009; 106 Y Saito (1891_CR32) 2001; 435 M Heilig (1891_CR20) 2006; 111 U Shalev (1891_CR34) 2002; 54 GJ Hervieu (1891_CR22) 2000; 12 F Weiss (1891_CR38) 1993; 267 TJ Kowalski (1891_CR25) 2007; 21 FL Goodwin (1891_CR19) 1998; 22 Y Chen (1891_CR8) 2002; 143 A Cippitelli (1891_CR10) 2005; 21 RJ DiLeone (1891_CR12) 2003; 73 DJ Marsh (1891_CR27) 2002; 99 C Morens (1891_CR28) 2005; 1062 PW Kalivas (1891_CR23) 2003; 168 S Chaki (1891_CR7) 2005; 11 DR Gehlert (1891_CR16) 2009; 329 DG Smith (1891_CR35) 2005; 25 S Chaki (1891_CR6) 2003; 304 NW Gilpin (1891_CR18) 2004; 78 AC Catania (1891_CR5) 1992 SG Nair (1891_CR29) 2009; 205 A Cippitelli (1891_CR11) 2008; 198 H Kawauchi (1891_CR24) 1983; 305 MA Bednarek (1891_CR1) 2002; 41 CP Tan (1891_CR37) 2002; 79 EA Duncan (1891_CR15) 2007; 31 D Georgescu (1891_CR17) 2005; 25 RA Wise (1891_CR39) 2004; 5 B Borowsky (1891_CR3) 2002; 8 DG Smith (1891_CR36) 2006; 31 |
References_xml | – volume: 64 start-page: 184 year: 2008 end-page: 191 ident: CR30 article-title: Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2007.12.011 – volume: 11 start-page: 341 year: 2005 end-page: 352 ident: CR7 article-title: ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety publication-title: CNS Drug Rev – volume: 73 start-page: 759 year: 2003 end-page: 768 ident: CR12 article-title: Lateral hypothalamic neuropeptides in reward and drug addiction publication-title: Life Sci doi: 10.1016/S0024-3205(03)00408-9 – volume: 78 start-page: 65 year: 2004 end-page: 73 ident: CR18 article-title: Sedative and motor-impairing effects of neuropeptide Y and ethanol in selectively bred P and NP rats publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2004.02.012 – volume: 143 start-page: 2469 year: 2002 end-page: 2477 ident: CR8 article-title: Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity publication-title: Endocrinology doi: 10.1210/en.143.7.2469 – volume: 21 start-page: 2243 year: 2005 end-page: 2251 ident: CR10 article-title: Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2005.04056.x – volume: 435 start-page: 26 year: 2001 end-page: 40 ident: CR32 article-title: Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain publication-title: J Comp Neurol doi: 10.1002/cne.1191 – volume: 29 start-page: 958 year: 2005 end-page: 964 ident: CR13 article-title: Central administration of melanin-concentrating hormone increases alcohol and sucrose/quinine intake in rats publication-title: Alcohol Clin Exp Res doi: 10.1097/01.ALC.0000167741.42353.10 – volume: 85 start-page: 728 year: 2006 end-page: 735 ident: CR14 article-title: The regulation of alcohol intake by melanin-concentrating hormone in rats publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2006.11.004 – volume: 22 start-page: 837 year: 1998 end-page: 844 ident: CR19 article-title: Do taste factors contribute to the mediation of ethanol intake? Ethanol and saccharin-quinine intake in three rat strains publication-title: Alcohol Clin Exp Res – volume: 168 start-page: 3 year: 2003 end-page: 20 ident: CR33 article-title: The reinstatement model of drug relapse: history, methodology and major findings publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-002-1224-x – volume: 31 start-page: 1135 year: 2006 end-page: 1145 ident: CR36 article-title: Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300881 – volume: 5 start-page: 483 year: 2004 end-page: 494 ident: CR39 article-title: Dopamine, learning and motivation publication-title: Nat Rev Neurosci doi: 10.1038/nrn1406 – volume: 8 start-page: 825 year: 2002 end-page: 830 ident: CR3 article-title: Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist publication-title: Nat Med – year: 1992 ident: CR5 publication-title: Learning – volume: 99 start-page: 3240 year: 2002 end-page: 3245 ident: CR27 article-title: Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.052706899 – volume: 16 start-page: 4723 year: 2006 end-page: 4727 ident: CR21 article-title: The discovery and optimization of pyrimidinone-containing MCH R1 antagonists publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2006.07.008 – volume: 319 start-page: 218 year: 1992 end-page: 245 ident: CR2 article-title: The melanin-concentrating hormone system of the rat brain: an immuno-and hybridization histochemical characterization publication-title: J Comp Neurol doi: 10.1002/cne.903190204 – volume: 1062 start-page: 32 year: 2005 end-page: 38 ident: CR28 article-title: Effects of MCH and a MCH1-receptor antagonist on (palatable) food and water intake publication-title: Brain Res – volume: 99 start-page: 811 year: 2004 end-page: 828 ident: CR4 article-title: Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review publication-title: Addiction doi: 10.1111/j.1360-0443.2004.00763.x – volume: 304 start-page: 818 year: 2003 end-page: 826 ident: CR6 article-title: Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-met hoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.102.044826 – volume: 31 start-page: 1325 year: 2007 end-page: 1337 ident: CR15 article-title: Alcohol drinking in MCH receptor-1-deficient mice publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2007.00427.x – volume: 12 start-page: 1194 year: 2000 end-page: 1216 ident: CR22 article-title: The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat publication-title: Eur J Neurosci doi: 10.1046/j.1460-9568.2000.00008.x – volume: 198 start-page: 449 year: 2008 end-page: 460 ident: CR11 article-title: Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1104-0 – volume: 25 start-page: 914 year: 2005 end-page: 922 ident: CR35 article-title: Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4079-04.2005 – volume: 205 start-page: 129 year: 2009 end-page: 140 ident: CR29 article-title: Effects of the MCH1 receptor antagonist SNAP 94847 on high-fat food-reinforced operant responding and reinstatement of food seeking in rats publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-009-1523-6 – volume: 13 start-page: 26 year: 2008 end-page: 30 ident: CR31 article-title: Long-lasting tolerance to alcohol following a history of dependence publication-title: Addict Biol doi: 10.1111/j.1369-1600.2007.00079.x – volume: 54 start-page: 1 year: 2002 end-page: 42 ident: CR34 article-title: Neurobiology of relapse to heroin and cocaine seeking: a review publication-title: Pharmacol Rev doi: 10.1124/pr.54.1.1 – volume: 25 start-page: 2933 year: 2005 end-page: 2940 ident: CR17 article-title: The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1714-04.2005 – volume: 179 start-page: 366 year: 2005 end-page: 373 ident: CR26 article-title: Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-004-2036-y – volume: 79 start-page: 785 year: 2002 end-page: 792 ident: CR37 article-title: Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression publication-title: Genomics doi: 10.1006/geno.2002.6771 – volume: 267 start-page: 250 year: 1993 end-page: 258 ident: CR38 article-title: Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants publication-title: J Pharmacol Exp Ther – volume: 329 start-page: 429 year: 2009 end-page: 438 ident: CR16 article-title: Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.143362 – volume: 21 start-page: 311 year: 2007 end-page: 321 ident: CR25 article-title: Melanin-concentrating hormone receptor-1 antagonists as antiobesity therapeutics: current status publication-title: BioDrugs doi: 10.2165/00063030-200721050-00003 – volume: 168 start-page: 44 year: 2003 end-page: 56 ident: CR23 article-title: Brain circuitry and the reinstatement of cocaine-seeking behavior publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-003-1393-2 – volume: 111 start-page: 855 year: 2006 end-page: 876 ident: CR20 article-title: Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms publication-title: Pharm Therap doi: 10.1016/j.pharmthera.2006.02.001 – volume: 106 start-page: 6772 year: 2009 end-page: 6777 ident: CR9 article-title: The melanin-concentrating hormone system modulates cocaine reward publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0811331106 – volume: 41 start-page: 6383 year: 2002 end-page: 6390 ident: CR1 article-title: Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1 publication-title: Biochemistry (Mosc) doi: 10.1021/bi0200514 – volume: 305 start-page: 321 year: 1983 end-page: 323 ident: CR24 article-title: Characterization of melanin-concentrating hormone in Chum Salmon Pituitaries publication-title: Nature doi: 10.1038/305321a0 – volume: 111 start-page: 855 year: 2006 ident: 1891_CR20 publication-title: Pharm Therap doi: 10.1016/j.pharmthera.2006.02.001 – volume: 31 start-page: 1135 year: 2006 ident: 1891_CR36 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300881 – volume: 79 start-page: 785 year: 2002 ident: 1891_CR37 publication-title: Genomics doi: 10.1006/geno.2002.6771 – volume: 21 start-page: 2243 year: 2005 ident: 1891_CR10 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2005.04056.x – volume: 25 start-page: 914 year: 2005 ident: 1891_CR35 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4079-04.2005 – volume: 319 start-page: 218 year: 1992 ident: 1891_CR2 publication-title: J Comp Neurol doi: 10.1002/cne.903190204 – volume: 198 start-page: 449 year: 2008 ident: 1891_CR11 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1104-0 – volume: 143 start-page: 2469 year: 2002 ident: 1891_CR8 publication-title: Endocrinology doi: 10.1210/endo.143.7.8903 – volume: 85 start-page: 728 year: 2006 ident: 1891_CR14 publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2006.11.004 – volume: 22 start-page: 837 year: 1998 ident: 1891_CR19 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.1998.tb03876.x – volume: 267 start-page: 250 year: 1993 ident: 1891_CR38 publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)39420-6 – volume: 64 start-page: 184 year: 2008 ident: 1891_CR30 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2007.12.011 – volume: 54 start-page: 1 year: 2002 ident: 1891_CR34 publication-title: Pharmacol Rev doi: 10.1124/pr.54.1.1 – volume: 12 start-page: 1194 year: 2000 ident: 1891_CR22 publication-title: Eur J Neurosci doi: 10.1046/j.1460-9568.2000.00008.x – volume: 179 start-page: 366 year: 2005 ident: 1891_CR26 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-004-2036-y – volume: 11 start-page: 341 year: 2005 ident: 1891_CR7 publication-title: CNS Drug Rev doi: 10.1111/j.1527-3458.2005.tb00052.x – volume: 168 start-page: 44 year: 2003 ident: 1891_CR23 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-003-1393-2 – volume: 21 start-page: 311 year: 2007 ident: 1891_CR25 publication-title: BioDrugs doi: 10.2165/00063030-200721050-00003 – volume: 435 start-page: 26 year: 2001 ident: 1891_CR32 publication-title: J Comp Neurol doi: 10.1002/cne.1191 – volume: 205 start-page: 129 year: 2009 ident: 1891_CR29 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-009-1523-6 – volume: 31 start-page: 1325 year: 2007 ident: 1891_CR15 publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2007.00427.x – volume: 13 start-page: 26 year: 2008 ident: 1891_CR31 publication-title: Addict Biol doi: 10.1111/j.1369-1600.2007.00079.x – volume-title: Learning year: 1992 ident: 1891_CR5 – volume: 99 start-page: 3240 year: 2002 ident: 1891_CR27 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.052706899 – volume: 16 start-page: 4723 year: 2006 ident: 1891_CR21 publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2006.07.008 – volume: 99 start-page: 811 year: 2004 ident: 1891_CR4 publication-title: Addiction doi: 10.1111/j.1360-0443.2004.00763.x – volume: 168 start-page: 3 year: 2003 ident: 1891_CR33 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-002-1224-x – volume: 106 start-page: 6772 year: 2009 ident: 1891_CR9 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0811331106 – volume: 304 start-page: 818 year: 2003 ident: 1891_CR6 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.102.044826 – volume: 329 start-page: 429 year: 2009 ident: 1891_CR16 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.143362 – volume: 8 start-page: 825 year: 2002 ident: 1891_CR3 publication-title: Nat Med doi: 10.1038/nm0902-1039b – volume: 78 start-page: 65 year: 2004 ident: 1891_CR18 publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2004.02.012 – volume: 1062 start-page: 32 year: 2005 ident: 1891_CR28 publication-title: Brain Res doi: 10.1016/j.brainres.2005.09.005 – volume: 25 start-page: 2933 year: 2005 ident: 1891_CR17 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1714-04.2005 – volume: 5 start-page: 483 year: 2004 ident: 1891_CR39 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1406 – volume: 41 start-page: 6383 year: 2002 ident: 1891_CR1 publication-title: Biochemistry (Mosc) doi: 10.1021/bi0200514 – volume: 73 start-page: 759 year: 2003 ident: 1891_CR12 publication-title: Life Sci doi: 10.1016/S0024-3205(03)00408-9 – volume: 29 start-page: 958 year: 2005 ident: 1891_CR13 publication-title: Alcohol Clin Exp Res doi: 10.1097/01.ALC.0000167741.42353.10 – volume: 305 start-page: 321 year: 1983 ident: 1891_CR24 publication-title: Nature doi: 10.1038/305321a0 |
SSID | ssj0000484 ssj0068394 |
Score | 2.2023983 |
Snippet | Rationale
Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains... Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant... Rationale: Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains... RATIONALE: Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains... |
SourceID | swepub proquest pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 367 |
SubjectTerms | Alcohol Alcohol Drinking - prevention & control Animal behavior Animals Anti-Obesity Agents - administration & dosage Anti-Obesity Agents - pharmacology Biological and medical sciences Biomedical and Life Sciences Biomedicine Dose-Response Relationship, Drug Drug addictions Drug Delivery Systems Footshock Hormones Male MCH1-R Medical sciences Miscellaneous Motor Activity - drug effects Neurosciences Original Investigation Pharmacology. Drug treatments Pharmacology/Toxicology Psychiatry Psychopharmacology Pyrimidinones - administration & dosage Pyrimidinones - pharmacology Rats Rats, Wistar Receptors, Somatostatin - antagonists & inhibitors Reinstatement Reward Rodents Saccharin Secondary Prevention Seeking Self Administration Taste - drug effects Thiophenes - administration & dosage Thiophenes - pharmacology Toxicology |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBdbB2MwytZ9ud2KHkbYRwWKP-ToMXQrYZBRRrP1zci2tBlSudjJg_-Z_a27s_yxjBLYm411p8Q6ST_57ndHyNtAGiE0l0xluYEDSihZGumYaaOk8WOtRMt6X34Vi1X45Tq67njcdR_t3rsk25V6ILvhdoSxP-iLlFPW3CcPIji6YxzXyp-Py2-IzEt3I2D7d3mYA2SRRbPer3mXvp2d6fGtquElGVfd4i74-Zfr9J80o-3WdPGEHHaYks6dETwl97Q9Ig-Xndf8iEwuXX7q5oxejXSr-oxO6OWYubp5Rn5jjU8XGGtpaahy9XNprdeGqZ00u1TZnFa6sC0jCT8x7gpo_ARP04be6LWyhWUZ8iNtKw0PfgFULq0GDRhWU1Z0St8tzxdT9u09aEZPGXR1QwtLfyDArSjI1c_J6uLz1fmCdQUcWBbGfMNCA4DQaICgmcl5LqSfBpkQJo_iTPsAhvIMr5WMZD41nCtuZJzDkmNSY8IoDF6QAws_5hWhWR74gORSpVLAHD5XIjURzALYTPWMa-0R3g9eknXZzbHIxjoZ8jK3451wvIfxThqPfBhEbl1qj32NT3csYpDAI5yYzaRHTnoTSbploE5iALcS2cYeocNTmL_olFFWl1toEoQIg8NgTxNEuZjVxyMvne2NvSMFFlR45GNvjGPve_7MxNnroAeTjH8qvs-TsvqZrIstRv7B0f_4v9SekEcutgIj8F6Tg0211W8Asm3S03aK_gEDDjrb priority: 102 providerName: Springer Nature |
Title | Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar rats |
URI | https://link.springer.com/article/10.1007/s00213-010-1891-y https://www.ncbi.nlm.nih.gov/pubmed/20628734 https://www.proquest.com/docview/722692227 https://www.proquest.com/docview/734008343 https://www.proquest.com/docview/754568156 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-101840 |
Volume | 211 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgV0JICMHyCguVD6jisRZu3jmhdmmpQK2q1RbKKXISGyJ1ndK0h_4ZfiszcZJShHpKI7-Sztj-4pn5hpBXTqR8X_KIiTRT8IHiRizxZMCkEpGyAyn8Kup9MvXHc_fzwlvUvjll7VbZrInVQp0VKZ6Rvw8AJ0QYuPlh9Yth0ig0rtYZNG6TU2QuQ6UOFsF-IXYxBtPc-AAEDCOzg_FkXthYOHlFKGpjjgP0UwijHtsd7FH3VqKEv0uZPBf_A6J_GVH_IRytNqnRA3K_Rpe0b9ThIbkl9Rm5M6nt52ekOzNM1bsLer0PvCovaJfO9hzWu0fkN2b7NC6ymhaKCpNJl5ZyqZg4INylQmd0LXNdxSbhYeNhA4mH8TTZ0Ru5FDrXLMVISV21hoKfAJoLLaEHdLAp1rRHX08uxz129QZ6RpsZDHVDc02_IdRdU2hXPibz0fD6cszqVA4sdQO-Ya4CaKgkgNFUZTwDSSZO6vsq84JU2gCLshR_CxBi1lOcC66iIIPFRyVKuZ7rPCEnGh7mGaFp5tiA6RIhEkAfNhd-ojyYD7CtypBLaRHeCC9Oa55zTLexjFuG5kreMcd7kHe8s8jbtsnKkHwcq9w50Ii2BX7M-WEYWeS8UZG4XhDKuFVfi9C2FGYymmeElsUWqjguAmLXOVIF8S7y-1jkqdG9_egYDAtdWORdo4z70Y-8TNfoa9sP0o1_zL_242L9I17mW_QBDF3-_OhLnZO7xqsCfe9ekJPNeitfAljbJJ1qSnbIaX80GEzx-un7lyFcB8Pp7ApK53b_D_v2QxU |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgESQlBeplD2ABGPWmz89gGhqqVKaVNVKC25mbW9C5HSdYgTIf8Z_gH_kRlv7BCEcustlndmY83s7Lc7L4AXbqyCQPLYFlmu8IDixXbqy9CWSsTKCaUI6qz3_mnQO_c-Df3hBvxucmEorLKxibWhzouM7sjfhYgTYkrc_DD5YVPTKHKuNh00jFYcy-onntjK90cHKN6XjnP4cbDfsxdNBezMC_nM9hSCFCURFmUq5znyTN0sCFTuh5l0cIPOM_otYj_Ou4pzwVUc5rgMVKqU53su8r0G13Hf5XTWC4fh0vB7lPNpHgIEHqYCtEv5a37UeFR5XcDUoZ4KFBcRxV27WtkTb09EieJRpq_G_4DvX07bfwqc1pvi4V24s0CzbM-o3z3YkHoLbvQX_vot6JyZytjVLhssE73KXdZhZ8ua2dV9-EXdRU1IrmaFYsJ07mWlHCtbrBT4ZULnbCpHus6FosvNVQJJl_8srdilHAs90nZGmZm6psYX3xGkF1oiBwroKaasy17193td-_Nr5Ew-Opzqko00-0LQesqQrnwA51ci5YewqfHPPAaW5a6DGDIVIkW043ARpMrH9YfbuIy4lBbwRnhJtqirTu09xklbEbqWd8LpGeWdVBa8aUkmpqjIusE7KxrRUtDhMYii2ILtRkWShQEqk3a5WMDat2g5yB0ktCzmOMT1CIB77pohhK-pnpAFj4zuLWen5FtkYcHbRhmXs6_5mI7R15YPlTc_GF3sJcX0WzIezSnmMPL4k7Uf9Rxu9gb9k-Tk6PR4G26ZiA6K-3sKm7PpXD5DoDhLd-rlyeDrVduDP5dHe1c |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB2VVKqQEIJyM4WyDxBxqdWN735AqDStUkqiqGpL38za3oVIqR3iRMg_w3_wd8x47YQglLe-xfLuONbMzp71zJwBeGmHyvMkD02RpAoPKE5oxq70TalEqCxfCq-qeu8PvN6F8-nKvdqA300tDKVVNj6xctRpntA38n0fcUJIhZv7qs6KGHaPP0x-mNRAigKtTTcNbSGnsvyJp7fi_UkXVf3Kso6Pzg97Zt1gwEwcn89MRyFgURIhUqJSnqL82E48T6Wun0gLN-s0od8idMO0ozgXXIV-iktCxUo5rmOj3Fuw6dOhqAWbH48Gw7PlNuBQBai-8BCGaD5om6rZ3KCJr_KKztSiDguUJRGEHbNc2SHvTESBylK6y8b_YPBfIdx_6E6rLfL4HtytsS070MZ4HzZktg1b_Tp6vw3toebJLvfY-bLsq9hjbTZcMmiXD-AX9RrVCboZyxUTuo8vK-RYmWKF7peJLGVTOcqqyij61Lk6QVIogMUlu5ZjkY0yM6E6zayajTe-I2TPM4kSKL0nn7IOe90_7HXMszcomSJ2-KhrNsrYFwLaU4bziodwcSN6fgStDP_ME2BJaluIKGMhYsQ-FhderFxcjbipy4BLaQBvlBclNcs6NfsYRwt-6ErfEadr1HdUGvB2MWWiKUbWDd5dsYjFDDpKekEQGrDTmEhUu6MiWiweA9jiLvoRCg6JTOZzHGI7BMcde80QQtvELmTAY217y6dTKS6KMOBdY4zLp695mba214UcIjvvji4Ponz6LRqP5pSBGDj86dqXegFb6AuizyeD0x24rdM7KAnwGbRm07l8jqhxFu_W65PB15t2CX8A0LqA8g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Suppression+of+alcohol+self-administration+and+reinstatement+of+alcohol+seeking+by+melanin-concentrating+hormone+receptor+1+%28MCH1-R%29+antagonism+in+Wistar+rats&rft.jtitle=Psychopharmacology&rft.au=Cippitelli%2C+Andrea&rft.au=Karlsson%2C+Camilla&rft.au=Shaw%2C+Janice+L&rft.au=Thorsell%2C+Annika&rft.date=2010-09-01&rft.pub=Springer+Nature+B.V&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=211&rft.issue=4&rft.spage=367&rft_id=info:doi/10.1007%2Fs00213-010-1891-y&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=2092550581 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |